| abstract |
The present invention relates to a compound represented by chemical formula (1), a pharmaceutically acceptable salt thereof, a hydrate, a solvate, a prodrug, a tautomer, an enantiomer, or a pharmaceutically acceptable diastereomer, a method for preparing same, and a pharmaceutical composition containing same and having effects of treating or preventing metabolic diseases. Chemical formula (1) is the same as defined in claim 1. |